Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15705891.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Through digital karyotyping of permanent medulloblastoma cell lines, we found that the homeobox gene OTX2 was amplified more than 10-fold in three cell lines. Gene expression analyses showed that OTX2 transcripts were present at high levels in 14 of 15 (93%) medulloblastomas with anaplastic histopathologic features. Knockdown of OTX2 expression by siRNAs inhibited medulloblastoma cell growth in vitro, whereas pharmacologic doses of all-trans retinoic acid repressed OTX2 expression and induced apoptosis only in medulloblastoma cell lines that expressed OTX2. These observations suggest that OTX2 is essential for the pathogenesis of anaplastic medulloblastomas and that these tumors may be amenable to therapy with all-trans-retinoic acid.
Medical subject headings
- Antineoplastic Agents
- Brain Neoplasms
- Homeodomain Proteins
- Medulloblastoma
- Nerve Tissue Proteins
- Trans-Activators
- Tretinoin